Several Options to Monetize POET

• POET is a research company, not a product company

• POET/PET are ready to enter the commercialization process

• No single company is currently active in all market areas where POET provides a best-

  in-class value proposition; syndicate needed to extract full value from technology

  platform

Single Acquirer

• This path would involve selling POET to a single (by definition large) 3rd party

• Technology access/investment would likely be syndicated by acquirer

• Relatively small number of viable candidates

Multiple Acquirers

• This path would involve selling POET to a syndicate (likely structured as a joint

  venture)

• Ideal syndicate would include members with market presence in all key areas related

  to POET commercialization

  • Licensing

• Certain specialized market segments might be best addressed by licensing all or part

  of the POET/PET technology to one or more 3rd parties for use in a given market

• Can be complex with difficult-to-foresee implications for other activities